BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Deals

  Already Owning 40.8% of BlueRock Therapeutics, Bayer Buys Rest of Company for $600 Million

  Under the terms of the acquisition, Bayer is buying the rest of the company for $240 million up front with an additional $360 million in various development milestones. This will correspond with the company’s value of about $1 billion.

  August 8, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  BioCapital

  CMS Releases New Rules Overseeing CAR-T Immuno-Oncology Therapy

  The Centers for Medicare and Medicaid Services announced the agency would cover CAR-T so patients would have “consistent and predictable access” to the therapy.

  August 8, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  FDA

  Akcea and Ionis Gear Up for Second Attempt at Getting Waylivra FDA Approval

  Waylivra was rejected by the FDA last year but gained approval in Europe in May. The publication of final Phase III data in the New England Journal of Medicine could support a potential bid for regulatory approval in the U.S.

  August 8, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  2019 Best Cities for Work-Life Balance

  Landing a job that provides a positive work-life balance is essential for many would-be employees and is also an attractive feature that many hiring managers point to when trying to fill a position. A recent survey reveals that geography may play a key role in that sought-for balance.

  August 8, 2019

   · 

  4 min read

   · 

  Alex Keown
• 

  Policy

  Microbiome-Focused Companies Find New Ways to Protect IP

  Biopharma companies working with the microbiome are running into patent obstacles due to the difficulty in using the system to protect naturally-occurring substances.

  August 8, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  BioSpace Movers and Shakers, Aug. 9

  Biopharma companies strengthen their senior leadership teams and boards of directors.

  August 8, 2019

   · 

  8 min read

   · 

  Alex Keown
• Deals

  Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash

  Cambrex Corporation announced that it has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billion, including Cambrex’s net debt.

  August 8, 2019

   · 

  9 min read
• Business

  GBT Reports Recent Business Progress and Second Quarter 2019 Financial Results

  Global Blood Therapeutics, Inc. reported recent business progress and financial results for the second quarter ended June 30, 2019.

  August 8, 2019

   · 

  8 min read
• Business

  Catalyst Pharmaceuticals Announces Second Quarter 2019 Financial Results and Provides Corporate Update

  Catalyst Pharmaceuticals, Inc. reported financial results for the second quarter ended June 30, 2019 and provided a corporate update.

  August 8, 2019

   · 

  8 min read
• Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing

  Integrated package of new and established services saves time and minimizes risks

  August 8, 2019

   · 

  3 min read